Search Results

There are 19112 results for: content related to: A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma

  1. Immunohistochemical study of protein induced by vitamin K absence or antagonist II in hepatocellular carcinoma

    Journal of Surgical Oncology

    Volume 84, Issue 2, October 2003, Pages: 89–93, Hideyuki Ajisaka, Koichi Shimizu and Koichi Miwa

    Version of Record online : 16 SEP 2003, DOI: 10.1002/jso.10298

  2. You have free access to this content
    Multiplication of alpha-fetoprotein and protein induced by vitamin K absence-II is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy

    Hepatology Research

    Volume 45, Issue 10, October 2015, Pages: E21–E31, Toshiya Kamiyama, Hideki Yokoo, Tatsuhiko Kakisaka, Tatsuya Orimo, Kenji Wakayama, Hirofumi Kamachi, Yosuke Tsuruga, Kenichiro Yamashita, Tsuyoshi Shimamura, Satoru Todo and Akinobu Taketomi

    Version of Record online : 8 DEC 2014, DOI: 10.1111/hepr.12451

  3. Histological study of PIVKA-II expression in hepatocellular carcinoma and adenomatous hyperplasia

    Pathology International

    Volume 51, Issue 12, December 2001, Pages: 916–922, Upik Anderiani Miskad, Yoshihiko Yano, Miyuki Nakaji, Shinji Kishi, Hiroshi Itoh, Soo Ryang Kim, Yonson Ku, Yoshikazu Kuroda and Yoshitake Hayashi

    Version of Record online : 13 FEB 2002, DOI: 10.1046/j.1440-1827.2001.01296.x

  4. You have free access to this content
    Immunohistologic study on the expressions of α-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma

    Hepatology

    Volume 34, Issue 6, December 2001, Pages: 1128–1134, Miwako Fujioka, Yutaka Nakashima, Osamu Nakashima and Masamichi Kojiro

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2001.29202

  5. A multicenter study on PIVKA reference interval of healthy population and establishment of PIVKA cutoff value for hepatocellular carcinoma diagnosis in China

    International Journal of Laboratory Hematology

    X. Qin, G. Tang, R. Gao, Z. Guo, Z. Liu, S. Yu, M. Chen, Z. Tao, S. Li, M. Liu, L. Wang, L. Hou, L. Xia, X. Cheng, J. Han and L. Qiu

    Version of Record online : 20 MAR 2017, DOI: 10.1111/ijlh.12639

  6. Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma

    Liver International

    Volume 34, Issue 2, February 2014, Pages: 313–321, Hana Park, Seung Up Kim, Jun Young Park, Do Young Kim, Sang Hoon Ahn, Chae Yoon Chon, Kwang-Hyub Han and Jinsil Seong

    Version of Record online : 29 JUL 2013, DOI: 10.1111/liv.12274

  7. Immunolocalisation of PIVKA-II in paraffin-embedded specimens of hepatocellular carcinoma

    Liver

    Volume 19, Issue 5, October 1999, Pages: 406–410, Masaya Tamano, Hitoshi Sugaya, Motoo Oguma, Toshimitu Murohisa, Yutaka Tomita, Akira Matsumura, Kazuo Kojima and Akira Terano

    Version of Record online : 2 MAR 2007, DOI: 10.1111/j.1478-3231.1999.tb00069.x

  8. Abnormal prothrombin: Evaluation as a tumour marker and localization in tissues of patients with hepatocellular carcinoma

    Journal of Gastroenterology and Hepatology

    Volume 8, Issue 3, June 1993, Pages: 212–216, T. KODA, S. YAMAZAKI, I. TAMURA, H. NAKABA, T. TAKAO, S. KATAYAMA and O. KURIMURA

    Version of Record online : 10 MAR 2008, DOI: 10.1111/j.1440-1746.1993.tb01188.x

  9. Des-γ carboxy prothrombin (PIVKA-II) and α-fetoprotein producing gastric cancer with multiple liver metastases

    Pathology International

    Volume 53, Issue 4, April 2003, Pages: 236–240, Yoshihisa Takahashi and Tohru Inoue

    Version of Record online : 24 APR 2003, DOI: 10.1046/j.1320-5463.2003.01461.x

  10. Echis time, under-carboxylated prothrombin and vitamin K status in intensive care patients

    Clinical & Laboratory Haematology

    Volume 25, Issue 6, December 2003, Pages: 397–404, D. O'Shaughnessy, C. Allen, T. Woodcock, K. Pearce, J. Harvey and M. Shearer

    Version of Record online : 27 NOV 2003, DOI: 10.1046/j.0141-9854.2003.00547.x

  11. Clinical utility of tumor markers in hepatocellular and pancreatic carcinomas

    Journal of Hepato-Biliary-Pancreatic Surgery

    Volume 2, Issue 4, December 1995, Pages: 395–400, Hiroshi Takami and Tadahiro Takada

    Version of Record online : 1 DEC 1995, DOI: 10.1007/BF02349256

  12. You have full text access to this Open Access content
    Vitamin K Contents in Liver Tissue of Hepatocellular Carcinoma Patients

    Japanese Journal of Cancer Research

    Volume 91, Issue 1, January 2000, Pages: 68–74, Takayuki Miyakawa, Yasuhiro Kajiwara, Akira Shirahata, Kohji Okamoto, Hideaki Itoh and Keiichi Ohsato

    Version of Record online : 22 AUG 2005, DOI: 10.1111/j.1349-7006.2000.tb00861.x

  13. Protein induced by vitamin K absence or antagonist II (PIVKA-II) producing large cell neuroendocrine carcinoma (LCNEC) of lung with multiple liver metastases: A case report

    Pathology International

    Volume 67, Issue 2, February 2017, Pages: 105–109, Hirokazu Kurohama, Yumi Mihara, Yasumori Izumi, Masatsugu Kamata, Seiji Nagashima, Atsumasa Komori, Yojiro Matsuoka, Nozomi Ueki, Masahiro Nakashima and Masahiro Ito

    Version of Record online : 11 JAN 2017, DOI: 10.1111/pin.12499

  14. You have free access to this content
    Chapter 2: Diagnosis and surveillance

    Hepatology Research

    Volume 40, Issue s1, June 2010, Pages: 16–47,

    Version of Record online : 19 MAY 2010, DOI: 10.1111/j.1872-034X.2010.00655.x

  15. Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: relationship to prognosis

    HPB

    Volume 8, Issue 2, April 2006, Pages: 137–141, A. Nanashima, Y. Sumida, S. Tobinaga, K. Shibata, H. Shindo, M. Obatake, S. Shibasaki, N. Ide and Takeshi Nagayasu

    Version of Record online : 17 FEB 2009, DOI: 10.1080/13651820500273475

  16. You have free access to this content
    Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein

    Cancer

    Volume 73, Issue 10, 15 May 1994, Pages: 2464–2471, Taketoshi Suehiro, Keizo Sugimachi, Takashi Matsumata, Hidetoshi Itasaka, Akinobu Taketomi and Takashi Maeda

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19940515)73:10<2464::AID-CNCR2820731004>3.0.CO;2-9

  17. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma

    Journal of Surgical Oncology

    Volume 102, Issue 5, 1 October 2010, Pages: 490–496, Toshiro Masuda, Toru Beppu, Kei Horino, Hiroyuki Komori, Hiromitsu Hayashi, Hirohisa Okabe, Ryu Otao, Hasita Horlad, Takatoshi Ishiko, Hiroshi Takamori, Ken Kikuchi and Hideo Baba

    Version of Record online : 24 NOV 2009, DOI: 10.1002/jso.21451

  18. Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma

    Hepatology Research

    Volume 44, Issue 8, August 2014, Pages: 846–853, Fumitoshi Hirokawa, Michihiro Hayashi, Yoshiharu Miyamoto, Mitsuhiro Asakuma, Tetsunosuke Shimizu, Koji Komeda, Yoshihiro Inoue and Kazuhisa Uchiyama

    Version of Record online : 19 AUG 2013, DOI: 10.1111/hepr.12196

  19. You have free access to this content
    Evaluation of des-γ-carboxy prothrombin as a marker protein of hepatocellular carcinoma

    Cancer

    Volume 64, Issue 12, 15 December 1989, Pages: 2546–2551, Yoshihiro Deyashiki, Yoshimi Nishioka, Katsumi Takahashi, Yoshitane Kosaka and Koji Suzuki

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19891215)64:12<2546::AID-CNCR2820641223>3.0.CO;2-Q

  20. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates

    Intervention Review

    The Cochrane Library

    Renee M Puckett and Martin Offringa

    Published Online : 23 OCT 2000, DOI: 10.1002/14651858.CD002776